The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization
- PMID: 29212708
- PMCID: PMC5798295
- DOI: 10.1074/jbc.RA117.000751
The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization
Abstract
The pseudokinase group encompasses some 10% of protein kinases, but pseudokinases diverge from canonical kinases in key motifs. The two members of the small new kinase family 3 (NKF3) group are considered pseudokinases. These proteins, pseudopodium-enriched atypical kinase 1 (PEAK1, Sugen kinase 269, or SgK269) and pragmin (Sugen kinase 223 or SgK223), act as scaffolds in growth factor signaling pathways, and both contain a kinase fold with degraded kinase motifs at their C termini. These kinases may harbor regions that mediate oligomerization or control other aspects of signal transduction, but a lack of structural information has precluded detailed investigations into their functional roles. In this study, we determined the X-ray crystal structure of the PEAK1 pseudokinase domain to 2.3 Å resolution. The structure revealed that the PEAK1 kinase-like domain contains a closed nucleotide-binding cleft that in this conformation may deleteriously affect nucleotide binding. Moreover, we found that N- and C-terminal extensions create a highly unusual all α-helical split-dimerization region, termed here the split helical dimerization (SHED) region. Sequence conservation analysis suggested that this region facilitates a dimerization mode that is conserved between PEAK1 and pragmin. Finally, we observed structural similarities between the PEAK1 SHED region and the C-terminal extension of the Parkinson's disease-associated kinase PINK1. In summary, PEAK1's kinase cleft is occluded, and its newly identified SHED region may promote an unexpected dimerization mode. Similarities of PEAK1 with the active kinase PINK1 may reclassify the latter as a member of the new kinase family 3 group.
Keywords: PTEN-induced putative kinase (PINK1); crystal structure; dimerization; protein kinase; signal transduction.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.
Conflict of interest statement
The authors declare that they have no conflicts of interest with the contents of this article
Figures






References
-
- Wang Y., Kelber J. A., Tran Cao H. S., Cantin G. T., Lin R., Wang W., Kaushal S., Bristow J. M., Edgington T. S., Hoffman R. M., Bouvet M., Yates J. R. 3rd, and Klemke R. L. (2010) Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc. Natl. Acad. Sci. U.S.A. 107, 10920–10925 10.1073/pnas.0914776107 - DOI - PMC - PubMed
-
- Zheng Y., Zhang C., Croucher D. R., Soliman M. A., St-Denis N., Pasculescu A., Taylor L., Tate S. A., Hardy W. R., Colwill K., Dai A. Y., Bagshaw R., Dennis J. W., Gingras A. C., Daly R. J., et al. (2013) Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499, 166–171 10.1038/nature12308 - DOI - PMC - PubMed
-
- Kelber J. A., Reno T., Kaushal S., Metildi C., Wright T., Stoletov K., Weems J. M., Park F. D., Mose E., Wang Y., Hoffman R. M., Lowy A. M., Bouvet M., and Klemke R. L. (2012) KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Res. 72, 2554–2564 10.1158/0008-5472.CAN-11-3552,10.1158/1538-7445.AM2012-2554 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials